Metraipolis › archive › dc_9efe41fc5498

Immune Trajectories After Switch to Long-Acting Cabotegravir Plus Rilpivirine in the RELATIVITY Cohort — Europe PMC PMID:42921238

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42921238
DOI
10.1093/ofid/ofag583
License (as archived)
solo-consultazione
Archived
2026-10-31T09:01:19.881Z
SHA-256 of the archived text
c9406c2edf63ea3ea184ceb50713831e5df6139d0aa4fb1398b483ffdd325352
Stable URL of this page
https://metraipolis.com/documento/dc_9efe41fc5498

How to cite

Immune Trajectories After Switch to Long-Acting Cabotegravir Plus Rilpivirine in the RELATIVITY Cohort — Europe PMC PMID:42921238 — Europe PMC (en), https://europepmc.org/article/MED/42921238 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9efe41fc5498 (Metraipolis archive dc_9efe41fc5498, sha256 c9406c2edf63ea3ea184ceb50713831e5df6139d0aa4fb1398b483ffdd325352)
BibTeX
@misc{dc9efe41fc5498,
  title = {Immune Trajectories After Switch to Long-Acting Cabotegravir Plus Rilpivirine in the RELATIVITY Cohort — Europe PMC PMID:42921238},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42921238},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9efe41fc5498; sha256 c9406c2edf63ea3ea184ceb50713831e5df6139d0aa4fb1398b483ffdd325352},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42921238. Agents can read the archived copy with the MCP tool read_document.